Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine versus nalbuphine for prevention of propofol injection pain during gastroscopy
ChiCTR1900025438Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Sep 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nalbuphine, lidocaine and propofol in procedural pain (3 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoint: Pain. Planned start Sep 2019; status: not yet recruiting.
02
Drugs
nalbuphinelidocainepropofol
03
Conditions
procedural pain
Beyond the preview
Go deeper on ChiCTR1900025438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025438.